Question 1

What is the catalog number for CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice)?

Accepted Answer

The catalog number for CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice) is NBP3-28191-1mg.

Question 2

What sizes are available for CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice)?

Accepted Answer

CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice) is available in the following size(s): 1 mg.

Question 3

Is CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice) in stock?

Accepted Answer

CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 5

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

CHO Monoclonal Siglec-3/CD33 Antibody (vadastuximab) - Humanized - (Dry Ice)

Product Specifications

Frequently Asked Questions

Explore Other Products

Anti-LIGHT/Tnfsf14 Antibody Picoband®

Anti-Transcription factor SOX-2 SOX2 Antibody Picoband® (Dylight488 Conjugate)

Laminin (A5), Biotin conjugate, 0.1mg/mL

Anti-ZPI/SERPINA10 Antibody Picoband®

Complement C4d (C4D205), CF740 conjugate, 0.1mg/mL

CD73 (Immuno-Oncology Target) (NT5E/2545), 0.2mg/mL